title: [Vesiculobullous Sweet's syndrome].
authors.affiliation: Service de dermatologie UCL, cliniques universitaires Saint-Luc, 10, avenue Hippocrate, 1200 Woluwe-Saint-Lambert, Belgique. Electronic address: paujanssens@gmail.com.
authors.forename: P
authors.initials: P
authors.lastname: Janssens
authors.affiliation: Service de dermatologie, clinique Saint-Pierre (CSPO), 9, avenue Reine-Fabiola, 1340 Ottignies, Belgique.
authors.forename: C
authors.initials: C
authors.lastname: Courtin
authors.affiliation: Service de dermatologie, clinique Saint-Pierre (CSPO), 9, avenue Reine-Fabiola, 1340 Ottignies, Belgique.
authors.forename: A
authors.initials: A
authors.lastname: Saint-Remy
authors.affiliation: Service de dermatologie, clinique Saint-Pierre (CSPO), 9, avenue Reine-Fabiola, 1340 Ottignies, Belgique.
authors.forename: M-N
authors.initials: MN
authors.lastname: Voogeleer
authors.affiliation: Institut de pathologie et de génétique (IPG), 25, avenue Georges-Lemaître, 6041 Gosselies, Belgique.
authors.forename: P
authors.initials: P
authors.lastname: Ngendahayo
authors.affiliation: Service de dermatologie, clinique Saint-Pierre (CSPO), 9, avenue Reine-Fabiola, 1340 Ottignies, Belgique.
authors.forename: B
authors.initials: B
authors.lastname: Bouffioux
mesh_terms: D000005:Abdomen / Q000473:pathology*; D000368:Aged; D000741:Anemia, Aplastic / Q000150:complications* / Q000188:drug therapy; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D001374:Azacitidine / Q000008:administration & dosage / Q000009:adverse effects*; D017809:Fatal Outcome; D006801:Humans; D016867:Immunocompromised Host; D007279:Injections, Subcutaneous / Q000009:adverse effects; D008297:Male; D012772:Shock, Septic / Q000209:etiology; D016463:Sweet Syndrome / Q000150:complications*
chemical_list: D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine